irofulven has been researched along with Chromosomal Breakage in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konat, GW; Reed, E; Senft, J; Wang, W; Wang, Y; Wenger, SL; Wiltshire, T | 1 |
1 other study(ies) available for irofulven and Chromosomal Breakage
| Article | Year |
|---|---|
BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
Topics: Antineoplastic Agents; BRCA1 Protein; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Chromosome Breakage; DNA Damage; DNA Repair; Drug Resistance; Genomic Instability; Humans; Rad51 Recombinase; Sesquiterpenes | 2007 |